Eli Lilly and Company closed at $1,152.43 on September 18, 2026, advancing 1.25% in the most recent 24-hour session. The gain extended a broader weekly rally, with the stock up 2.60% over the past seven days.
Despite the near-term momentum, LLY remains under pressure on a longer time horizon. Shares have fallen 6.05% over the past 30 days, reflecting a meaningful pullback from higher levels reached earlier in the period.
Eli Lilly's market capitalization stood at $1,014.2 billion as of the close, keeping the pharmaceutical giant among the largest publicly traded companies by that measure. The figure reflects the scale of investor valuation relative to recent price movement.
The divergence between the stock's short-term gains and its 30-day decline illustrates the volatile trading pattern LLY has experienced heading into the final stretch of the session. Whether the weekly rebound can recover the broader monthly losses remains to be seen in the sessions ahead.
